Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11939394 Binding molecules that inhibit cancer growth
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
October 21, 2016
0
Date of Patent
March 26, 2024
0
Patent Application Number
15770317
0
Patent Citations
US Patent 8349574 Methods of determining patient response by measurement of Her-3
0
US Patent 8592562 Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
0
US Patent 8628774 Compositions and methods for treating and diagnosing cancer
0
US Patent 9220775 Binding molecules specific for HER3 and uses thereof
0
US Patent 9248181 Methods and means for the production of Ig-like molecules
0
US Patent 9248182 Methods and means for the production of Ig-like molecules
0
US Patent 9358286 Methods and means for the production of IG-like molecules
0
US Patent 9551208 Identifying uncertainty associated with a stimulated reservoir volume (SRV) calculation
0
US Patent 9758805 Methods and means for the production of Ig-like molecules
0
US Patent 9914777 Human CD3 binding antibody
0
•••
Patent Inventor Names
Bram Herpers
0
Ton Logtenberg
0
Eduard Batlle
0
Johannes Carolus Clevers
0
Mark Throsby
0
Robert Gerhardus Jacob Vries
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11939394
0
Patent Primary Examiner
Brad Duffy
0
Find more entities like US Patent 11939394 Binding molecules that inhibit cancer growth
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE